211 related articles for article (PubMed ID: 34311755)
1. The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
Guo X; Xuan M; Zheng H; Qin S; Wu H; Huang S; Wen Z
Trials; 2021 Jul; 22(1):491. PubMed ID: 34311755
[TBL] [Abstract][Full Text] [Related]
2. Chinese Herbal Formula Huoxiang Zhengqi for Dampness Pattern in Atopic Dermatitis and Diarrhea-Predominant Irritable Bowel Syndrome: Rationale and Design of a Master Protocol.
Huang Q; Guo X; Xuan M; Ouyang W; Wen Z
Evid Based Complement Alternat Med; 2021; 2021():5125568. PubMed ID: 34646325
[No Abstract] [Full Text] [Related]
3. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
[TBL] [Abstract][Full Text] [Related]
5. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
Xuan M; Guo X; Li H; Xie T; Mo X; Wen Z
Trials; 2021 Jan; 22(1):67. PubMed ID: 33468222
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
[TBL] [Abstract][Full Text] [Related]
7. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
Ji L; Zhao X; Zhang Y; Zhao P; Gong R; Li F; Huang H
Medicine (Baltimore); 2022 Mar; 101(9):e28895. PubMed ID: 35244043
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
Wang XX; Luo RJ; She B; Chen Y; Guo J
Trials; 2014 Jul; 15():273. PubMed ID: 25002196
[TBL] [Abstract][Full Text] [Related]
10. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
11. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
Liu N; Li J; Wang Y; Zhang S
J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
Zheng Y; Ching J; Cheng CW; Lam WC; Chan KL; Zhang X; Lam PY; Wu XY; Zhong LLD; Cao PH; Lo CW; Cheong PK; Lin Z; Koh M; Wu J; Bian ZX
Chin Med; 2021 Nov; 16(1):117. PubMed ID: 34774080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
Leighton MP; Lam C; Mehta S; Spiller RC
Trials; 2013 Jan; 14():10. PubMed ID: 23302220
[TBL] [Abstract][Full Text] [Related]
17. Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.
Ko SJ; Ryu B; Kim J; Hong BG; Yeo I; Lee BJ; Lee JM; Park JW
Trials; 2011 Oct; 12():219. PubMed ID: 21978382
[TBL] [Abstract][Full Text] [Related]
18. Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial.
Kim JI; Kim P; Lee JH; Kim YJ; Yang NR; Baeg MK; Choi JS; Kim HJ; Kim J; Sunwoo YY; Lee JH; Ha H; Park TY
BMJ Open; 2017 Dec; 7(11):e018362. PubMed ID: 29196484
[TBL] [Abstract][Full Text] [Related]
19. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
Kemppinen A; Howell C; Allgar V; Dodd M; Gregson J; Knowles C; McLaughlin J; Pandya P; Whorwell P; Markaryan E; Yiannakou Y
Trials; 2020 Jan; 21(1):122. PubMed ID: 32000822
[TBL] [Abstract][Full Text] [Related]
20. Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial.
Qi LY; Yang JW; Yan SY; She YF; Hu H; Li Y; Chi LL; Wu BQ; Tu JF; Wang LQ; Liu CZ
Trials; 2022 Aug; 23(1):711. PubMed ID: 36028847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
